LifeStance Health Group, Inc. (NASDAQ:LFST – Get Rating) shares dropped 3.4% during mid-day trading on Friday . The stock traded as low as $7.77 and last traded at $7.85. Approximately 190,470 shares changed hands during trading, a decline of 66% from the average daily volume of 565,161 shares. The stock had previously closed at $8.13.
Analyst Upgrades and Downgrades
Separately, TD Cowen downgraded shares of LifeStance Health Group from an “outperform” rating to a “market perform” rating and boosted their price target for the company from $8.00 to $9.00 in a report on Monday, May 15th. Two research analysts have rated the stock with a hold rating and four have given a buy rating to the stock. According to MarketBeat.com, LifeStance Health Group presently has a consensus rating of “Moderate Buy” and a consensus price target of $8.04.
LifeStance Health Group Trading Down 3.9 %
The firm has a fifty day moving average of $7.79 and a 200-day moving average of $6.12. The company has a quick ratio of 1.17, a current ratio of 1.17 and a debt-to-equity ratio of 0.15.
Insider Buying and Selling at LifeStance Health Group
In other news, insider Kevin Michael Mullins sold 97,266 shares of the firm’s stock in a transaction dated Monday, April 3rd. The stock was sold at an average price of $7.43, for a total transaction of $722,686.38. Following the sale, the insider now owns 5,512,581 shares of the company’s stock, valued at $40,958,476.83. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Over the last quarter, insiders have sold 264,066 shares of company stock valued at $1,744,368. 8.50% of the stock is currently owned by company insiders.
Institutional Inflows and Outflows
A number of hedge funds have recently bought and sold shares of the stock. JPMorgan Chase & Co. grew its stake in LifeStance Health Group by 25.6% in the first quarter. JPMorgan Chase & Co. now owns 109,813 shares of the company’s stock valued at $816,000 after purchasing an additional 22,367 shares in the last quarter. Cim Investment Management Inc. bought a new position in shares of LifeStance Health Group during the 1st quarter worth approximately $233,000. Susquehanna International Group LLP bought a new position in shares of LifeStance Health Group during the 1st quarter worth approximately $244,000. Jane Street Group LLC bought a new position in shares of LifeStance Health Group during the 1st quarter worth approximately $188,000. Finally, Squarepoint Ops LLC boosted its stake in shares of LifeStance Health Group by 243.4% during the 1st quarter. Squarepoint Ops LLC now owns 43,032 shares of the company’s stock worth $320,000 after acquiring an additional 30,501 shares during the period. 76.49% of the stock is currently owned by institutional investors.
LifeStance Health Group Company Profile
LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.
- Get a free copy of the StockNews.com research report on LifeStance Health Group (LFST)
- Big Lots Becomes A Stomach Churning Value Play
- The Melt-Up In Marvell Is On; But Don’t Chase It Higher
- Is Apple a Growth Stock or a Value Stock?
- Costco’s Earnings Call Reassure Economists, Recession Cancelled
- Hot Inflation, What It Means For The Summer Rally
Receive News & Ratings for LifeStance Health Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifeStance Health Group and related companies with MarketBeat.com's FREE daily email newsletter.